Krilogy Financial’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Sell
201,927
-2,141
-1% -$55.8K 0.16% 108
2026
Q1
$5.34M Buy
204,068
+4,673
+2% +$123K 0.17% 101
2025
Q4
$5.27M Buy
199,395
+3,375
+2% +$89.3K 0.18% 92
2025
Q3
$5.15M Buy
196,020
+16,040
+9% +$420K 0.19% 84
2025
Q2
$4.7M Sell
179,980
-25,388
-12% -$649K 0.27% 75
2025
Q1
$5.3M Buy
205,368
+27,027
+15% +$690K 0.34% 58
2024
Q4
$4.54M Buy
+178,341
New +$4.62M 0.3% 64

Other funds holding IBDZ

Krilogy Financial's IBDZ Position: Q2 2026 in Review

Krilogy Financial reduced its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 1% in Q2 2026, selling an estimated $55.8K and leaving 201,927 shares worth $5.26M. The position accounts for 0.16% of the portfolio, ranked #108.

Krilogy Financial first reported a position in IBDZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.34M in Q1 2026. 127 funds tracked by Wall St. Rank hold IBDZ as of Q2 2026.

  • Krilogy Financial held 201,927 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $5.26M as of Q2 2026.
  • Krilogy Financial sold 2,141 iShares iBonds Dec 2034 Term Corporate ETF shares in Q2 2026, an estimated $55.8K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 0.16% of Krilogy Financial's portfolio in Q2 2026, its #108 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Krilogy Financial's iShares iBonds Dec 2034 Term Corporate ETF position peaked at $5.34M in Q1 2026.
  • 127 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.